Abbott

Abbott Laboratories spreads its bets across four different health-care businesses. Its largest is medical devices, including the continuous glucose monitors that have become a mainstay for diabetics, followed by diagnostics, the testing systems that became a household name during the pandemic, a nutrition arm that makes brands like Ensure and Similac, and a division selling established medicines outside the United States. That diversification is the point: when one segment slows, another can pick up the slack, giving Abbott steadier results than a pure drug company. Founded in 1888 and based in Abbott Park, Illinois, it operates in more than 160 countries and is a dependable dividend payer with a long record of increases. The stock is a lower-volatility way to own health care, its performance driven by device innovation, testing demand and the steady, non-cyclical nature of medical spending.

On MyRWA, ABT trades tokenized across 13 on-chain venues - see the listings below.